These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Targetted inhibition of CD74 attenuates adipose COX-2-MIF-mediated M1 macrophage polarization and retards obesity-related adipose tissue inflammation and insulin resistance. Chan PC; Wu TN; Chen YC; Lu CH; Wabitsch M; Tian YF; Hsieh PS Clin Sci (Lond); 2018 Jul; 132(14):1581-1596. PubMed ID: 29773671 [TBL] [Abstract][Full Text] [Related]
4. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer. Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320 [TBL] [Abstract][Full Text] [Related]
5. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF. Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963 [TBL] [Abstract][Full Text] [Related]
6. Tumor Necrosis Factor α-Dependent Lung Inflammation Promotes the Progression of Lung Adenocarcinoma Originating From Alveolar Type II Cells by Upregulating MIF-CD74. Cao L; Wang X; Liu X; Meng W; Guo W; Duan C; Liang X; Kang L; Lv P; Lin Q; Zhang R; Zhang X; Shen H Lab Invest; 2023 Mar; 103(3):100034. PubMed ID: 36925198 [TBL] [Abstract][Full Text] [Related]
7. Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. McClelland M; Zhao L; Carskadon S; Arenberg D Am J Pathol; 2009 Feb; 174(2):638-46. PubMed ID: 19131591 [TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells. Xia W; Zhang F; Xie C; Jiang M; Hou M Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286 [TBL] [Abstract][Full Text] [Related]
9. CD74 expression and its therapeutic potential in thyroid carcinoma. Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560 [TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase. Fan H; Hall P; Santos LL; Gregory JL; Fingerle-Rowson G; Bucala R; Morand EF; Hickey MJ J Immunol; 2011 Apr; 186(8):4915-24. PubMed ID: 21411731 [TBL] [Abstract][Full Text] [Related]
11. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer. Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415 [TBL] [Abstract][Full Text] [Related]
12. Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas. Brock SE; Rendon BE; Yaddanapudi K; Mitchell RA J Biol Chem; 2012 Nov; 287(45):37917-25. PubMed ID: 22988252 [TBL] [Abstract][Full Text] [Related]
13. Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI. Xiong C; Huang B; Cun Y; Aghdasi BG; Zhou Y Clin Orthop Relat Res; 2014 Jun; 472(6):1943-54. PubMed ID: 24569872 [TBL] [Abstract][Full Text] [Related]
14. Dissociation of MIF-rpS3 complex and sequential NF-κB activation is involved in IR-induced metastatic conversion of NSCLC. Youn H; Son B; Kim W; Jun SY; Lee JS; Lee JM; Kang C; Kim J; Youn B J Cell Biochem; 2015 Nov; 116(11):2504-16. PubMed ID: 25900216 [TBL] [Abstract][Full Text] [Related]